Cognitive Impairment in Depression Is Not Associated with Neuropathologic Evidence of Increased Vascular or Alzheimer-Type Pathology
|
|
- Darrell Cameron
- 6 years ago
- Views:
Transcription
1 Cognitive Impairment in Depression Is Not Associated with Neuropathologic Evidence of Increased Vascular or Alzheimer-Type Pathology John O Brien, Alan Thomas, Clive Ballard, Andrew Brown, Nicol Ferrier, Evelyn Jaros, and Robert Perry Background: Cognitive impairment is common in depression, but underlying mechanisms remain unknown. We examined whether increases in Alzheimer-type or vascular pathology are associated with cognitive impairments in elderly depressed subjects. Methods: Eleven subjects who had died during a welldocumented episode of DSM-IV major depression were included. Neuropathologic assessments, blind to group membership, included standardized assessment of neuritic plaques, neurofibrillary tangles, and Lewy Bodies in frontal, temporal, parietal, and occipital cortices. Braak staging of Alzheimer pathology was also performed. Cerebral microvascular disease was scored according to a previously validated scale, and a score for cerebral and systemic atheroma of large and medium sized arteries was obtained. Results: No subject had Lewy bodies. Plaque and tangle counts for all subjects were well within published norms for age-matched control subjects. There were no significant differences in plaque or tangle counts between subjects who were cognitively impaired (n 5) and those who were nonimpaired (n 6) during their depressive illness. Similarly, neither total microvascular pathology nor deep frontal microvascular pathology differed between the two groups. Conclusions: Our results indicate that the liability for some patients to develop cognitive impairment during a depressive episode is not related to an increase in Alzheimer-type or vascular neuropathologic change. This indicates that other mechanisms must underlie both the cognitive impairment associated with depression and the observation that depression is a risk factor for dementia. Biol Psychiatry 2001 Society of Biological Psychiatry From the Institute for the Health of the Elderly (JO, AT, CB, AB, EJ, RP) and the Department of Psychiatry (NF), University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom. Address reprint requests to John O Brien, D.M., Newcastle General Hospital, Wolfson Research Centre, Institute for the Health of the Elderly, Westgate Road, Newcastle upon Tyne NE4 6BE, United Kingdom. Received January 3, 2000; revised May 19, 2000; accepted May 26, Key Words: Depression, affective disorder, neuropathology, cognitive impairment, postmortem, elderly Introduction It is well known that depression, particularly in elderly subjects, is associated with a number of deficits in cognitive function (Abas et al 1990; Austin et al 1999; Beats et al 1996). These deficits, when severe, can resemble those seen in an organic dementia such as Alzheimer s disease, giving rise to the clinical syndrome of pseudo dementia and the emphasis placed on trying to obtain an accurate diagnosis in such patients (Bulbena and Berrios 1986; McAllister 1985). It is now clear that the relationship between cognitive impairments occurring as part of a depressive disorder and those seen in organic conditions is complex. Cognitive impairments occurring during depression do not always remit on recovery from illness. For example, Abas et al (1990) found that whereas 70% of depressed subjects were impaired on a learning task during illness, 30% remained impaired despite clinical recovery. The cause of such enduring cognitive deficits is unknown, though they may carry an adverse prognosis with regard to long-term outcome. Kral and Emery (1989) followed up 44 elderly patients who had previously suffered from what was thought to be depressive pseudodementia on the grounds that cognitive function reverted to premorbid levels following treatment. After an average follow-up of 8 years, 89% were felt to have developed Alzheimer s disease. Epidemiologic studies have shown that depression is an independent risk factor for dementia (Jorm et al 1991). These lines of evidence suggest that cognitive impairment occurring during a depressive illness may indicate an increased liability to subsequently develop dementia and, in particular, Alzheimer s disease. If so, neuropathologic study of such cases might be expected to show a greater burden of Alzheimer type pathology in those depressed subjects who develop significant cognitive dysfunction compared to those who do not Society of Biological Psychiatry /01/$20.00 PII S (00)
2 Neuropathology of Cognitive Impairment BIOL PSYCHIATRY 131 There are, however, other reasons why elderly depressed patients may develop cognitive impairments. It is now clear that neuropsychological deficits affect most domains tested and include problems with attention, learning and memory, frontal and executive tasks, as well as motivation (Abas et al 1990; Austin et al 1999; Beats et al 1996; Elliot 1998; Salloway et al 1996). It has also been suggested that some impairments, particularly those in learning and memory, may be associated with hippocampal damage due to the raised levels of corticosteroids known to be associated with depressive illness, particularly in the elderly (O Brien 1997). The recent demonstration of reduced hippocampal volume in depressed subjects that correlated with lifetime duration of depression (and therefore presumably exposure to corticosteroids) supports this view (Sheline et al 1999). Another possible explanation for depressed subjects developing cognitive impairment is the presence of cerebrovascular pathology. One of the most consistently observed abnormalities in elderly depressed subjects is of an increased frequency of hyperintensities in the white matter and subcortical grey matter visualized on magnetic resonance imaging (Coffey et al 1990; Figiel et al 1991; Greenwald et al 1996, 1998; O Brien et al 1996). These lesions are more common in depressed subjects with onset in late life (Figiel et al 1991; O Brien et al 1996; Salloway et al 1996) and have been associated with cognitive impairments both during the depressive episode (Salloway et al 1996) and at follow-up (Hickie et al 1997). Partly on the basis of these lesions and the link between depression and cardiovascular disorder, the notion of vascular depression has been proposed (Alexopoulos et al 1997; Hickie and Scott 1998; Krishnan and McDonald 1995). Because microvascular change is a cause of white matter hyperintensities on magnetic resonance imaging (MRI) (Chimowitz et al 1992) and such lesions are associated with cognitive impairments in depression, it is possible that cognitive impairments occurring during depressive episode may be related to an increase in microvascular pathology. There have been no previous studies of the neuropathologic basis of the cognitive impairments that occur during depression. We wished to test the hypothesis that such impairments would be associated with an increased burden of Alzheimer-type and/or microvascular pathology in cortical areas. Methods and Materials Subjects Cases were obtained from records of the Neuropathology Department and the Newcastle Brain Tissue Bank. All depressed cases were from referrals to a secondary care unit, the Brighton Clinic. All were inpatients except one who was attending the day hospital. Full ethical approval has been granted for this postmortem study and consent for postmortem examination obtained from the next of kin. Clinical Assessment Subjects were included if they were 60 years or over at death and had died during a well-documented episode of DSM-IV Major Depression (American Psychiatric Association 1994). They had all undergone extensive assessments including a full history, mental state examination, physical examination, screening blood tests and, in some cases, computed tomography (CT) or MRI scans. Subjects were excluded if they had committed suicide by violent means or had ever met DSM-IV criteria for dementia, schizophrenia, or other psychotic disorders, manic or hypomanic episode or a mood disorder due to a general medical condition. Subjects were divided into a cognitively impaired group who were significantly impaired when depressed, and a nonimpaired group who showed no evidence of impairment even when depressed. Neuropathologic Assessment All subjects received a full postmortem examination (except one whose body was taken by the undertakers after the brain was removed) and the delay to postmortem was recorded. The right hemisphere was fixed in 10% formalin and the brains were dissected in a standard manner (Perry et al 1990a). Blocks were taken from the frontal, temporal, parietal, and occipital cortices, the hippocampus, the cingulate, the basal ganglia, the cerebellum, the upper and lower midbrain, the pons and the medulla. Five m or20 m sections were cut, and sections were prepared on glass slides. These were stained with haematoxylin and eosin (H&E), luxol fast blue (LFB) and/or Loyez (myelin), cresyl fast violet (CFV) or Nissl, methanamine silver and/or von Braunmuhl (plaques), Palmgren and/or tau-2 (tangles) and ubiquitin (Lewy bodies). These were then examined by experienced neuropathologists (RP and EJ) Subjects were excluded if they met neuropathologic criteria for any neurodegenerative disease such as Alzheimer s disease or dementia with Lewy bodies. Assessment of Alzheimer and Lewy Body Pathology Histopathologic analysis was carried out to quantify the number of neuritic plaques and neurofibrillary tangles in the four neocortical lobes (Perry et al 1990a, 1996). Both neuritic and diffuse plaques were counted in five fields (including gyral crests and sulcal depths and including all cortical layers) from each neocortical lobe (frontal, temporal, parietal, occipital). A mean score was obtained and converted to numbers per mm 2. Neocortical tangles were also counted in a similar manner, except the count used was the mean of the fields across all the cortical layers. Alzheimer-type pathology was staged according to the procedure of Braak and Braak (1991), assessing neurofibrillary tangles and neuropil threads in different parts of the hippocampus (stages 1 4) and neocortex (stages 5 and 6). Reliability was assessed by the single operator responsible for the study rating 10 subjects
3 132 BIOL PSYCHIATRY J. O Brien et al selected at random on 5 occasions for plaque and tangle counts. Co-efficients of variation (SD/mean) were 0% for tangle counts and 5.3% for plaque counts. Assessment of Large and Medium-Sized Arteries The extent of atheromatous degeneration in the coronary arteries, cerebral carotid and vertebrobasilar systems, and aorta was rated on a semiquantitative 0 3 scale (RP and AT). 0 none; 1 mild: atheroma only mild and patchy; 2 moderate: more extensive atheroma with less than 50% luminal stenosis; 3 severe: atheroma widespread with greater than 50% luminal stenosis in at least one vessel. An overall atheroma score was obtained for each subject by adding together the scores from each site. Assessment of Small Arteries and Arterioles For assessing microvascular disease the sections stained with H&E, LFB, and/or Loyez and Nissl from the frontal, temporal, parietal, and occipital cortices were used. In addition, large full-face coronal blocks were taken from the frontal and occipital cortices to include all the deep white matter in these two areas, coronal levels 4/5 and 27 (Perry 1993). Ten- m or 20- m sections were prepared on large (3 2 ) slides and stained with H&E, LFB, and/or Loyez (myelin) and Nissl. Microvascular disease was then scored blind to diagnosis by two raters (RP and AT) in each neocortical area in accordance with a scale previously used in vascular dementia (Esiri et al 1997). Briefly, this is a 0 3 scale in which 0 normal; 1 dilatation of perivascular spaces or hyaline thickening or a few perivascular macrophages; 2 dilatation of perivascular spaces or hyaline thickening plus mild to moderate perivascular pallor of myelin staining or loosening of the nerve fibres or nerve cells with gliosis; 3 Binswanger s disease (2 plus more widespread myelin pallor, nerve fibre or nerve cell disruption and gliosis). An overall microvascular score was calculated for each subject by adding together the scores for each neocortical area. A separate score was obtained by assessment of the frontal deep white matter. Statistical Analysis The two groups were compared statistically using standard software. Minitab (version 12; Minitab, State College, PA) was used to carry out Mann Whitney tests for the quantitative data (age, post-mortem interval, plaques, tangles, Lewy bodies) and StatXact (version 4, Cytel Software, Cambridge, MA) was used to carry out Fisher Freeman Halton test (more appropriate than 2 because of the low cell frequency) for the categorical data (sex, Braak, atheroma, and microvascular scores). Results Eleven subjects were studied. Eight suffered from recurrent unipolar depression, and all but one were depressed at death. All except one had received past treatment with electroconvulsive therapy. Five subjects were cognitively impaired when depressed. Of these, two had such marked psychomotor retardation that meaningful standardized cognitive testing was not possible, though both were clearly clinically very impaired, as for a time genuine doubt existed as to whether or not they had an organic dementia or a depressive pseudodementia. Testing of the other three showed scores in the impaired range on either the Mini-Mental State Examination (MMSE, maximum score 30; Folstein et al 1975) or the Mental Test Score (MTS, maximum score 37; Blessed et al 1968). One subject had an MMSE score of 22; the others had MTS scores of 22 and 25. Six subjects showed no clinical evidence of cognitive impairment. Two were recorded in casenotes as having undergone cognitive testing and being completely oriented, with normal concentration and memory, although neither the MMSE nor MTS was completed. Tests on the other four revealed MMSE scores of 28 and 29 and MTS scores of 36 and 37. Cause of death for the cognitively impaired patients was carcinoma (n 2) and bronchopneumonia (n 3). Cause of death for the nonimpaired patients was cardiac arrest (n 3), suicide (n 1), pulmonary embolus (n 1) and congestive cardiac failure (n 1). Four of the five cognitively impaired patients had failed to respond to adequate courses of two different antidepressants. Of unimpaired subjects, two had failed to respond to adequate courses of two different antidepressants, two had shown some response but were still depressed, and two died without apparent response to an antidepressant. Subject characteristics and results are shown in Table 1, whereas Table 2 contains a detailed breakdown of neuropathologic scores for each subject. For comparison, scores are also presented in Table 2 from published data on control and demented subjects of very similar age obtained using the same methodology (Perry et al 1996). There were no significant differences in age (t 36, p.31) or postmortem delay (t 22, p.31), but there was a trend toward a difference in gender (Fisher statistic 4.8, p.06), because all five cognitively impaired depressed subjects were female. No statistical differences were found between the groups on Alzheimer-type pathology (p.41) or Lewy body pathology (p 1.00, no Lewy bodies were seen in any case). The total atheroma and total microvascular scores were very similar (Fisher statistic 1.42, p.70 and Fisher statistic 4.31, p.51, respectively) and, although the frontal microvascular scores were slightly higher in the nonimpaired group, this did not approach significance statistically (Fisher statistic 6.9, sig. 0.23). As seen in Table 2, levels of Alzheimer type pathology is comparable to that of similarly aged normal control subjects and much less than found in Alzheimer s disease.
4 Neuropathology of Cognitive Impairment BIOL PSYCHIATRY 133 Table 1. Comparison of Cognitively Impaired and Nonimpaired Groups Impaired Nonimpaired Test statistic Significance Age (years) a 79.0 (4.69) 73.0 (8.81) Gender (male/female) b 0/5 4/ Postmortem delay (hours) a 47.5 (28.62) 27.8 (6.34) Total atheroma score b Total microvascular score b Deep white matter frontal microvascular b Neocortical plaques (per mm 2 ) a 1.4 (1.27) 0.98 (1.41) Neocortical tangles (per mm 2 ) a 0.2 (0.39) 0 (0) Braak stage b Lewy bodies (per cm 2 ) a 0 (0) 0 (0) Not applicable 1.00 a Values are mean (SD) and comparisons are made using the Mann Whitney test. b Values are medians and comparisons are made using the Fisher Freeman Halton test. Discussion This is the first study to investigate neuropathologic changes in depressed subjects with and without cognitive impairment. We found no evidence of increased neuropathologic abnormalities in the form of Alzheimer-type pathology or microvascular change in depressed subjects who developed cognitive impairment during depression compared to those who did not. A relationship with Alzheimer pathology might have been expected because of the similarity of some aspects of cognitive dysfunction in depression to those seen in Alzheimer s disease (Abas et al 1990), the high proportion of cognitively impaired depressed patients who subsequently develop the disorder (Kral and Emery 1989), and the fact that depression is a risk factor for Alzheimer s disease (Jorm et al 1991). The original study of Blessed et al (1968) which found a correlation, now replicated by several groups, between plaque count and cognitive test score in dementia included some cases with functional illness, seven of whom were depressed; however, our more detailed study (which does not include any of the same cases used by Blessed et al) shows that this well-recognized relationship in dementia does not apply to cognitive impairment in depression. Minimal Alzheimer-type pathology was seen in the depressed cases, of the same order as would be expected in age-matched control subjects (Perry et al 1990b). Microvascular pathology was also not extensive using currently available methods of assessment (Esiri et al 1997). Although the link between vascular disease and late life depression is well recognised (Hickie and Scott 1998), such pathology did not explain the occurrence of signifi- Table 2. Neuropathologic Scores in Two Depressed Groups Cognitive impairment Total atheroma Total microvascular Deep frontal microvascular Plaques per mm 2 Tangles per mm 2 Braak stage Lewy bodies Impaired Impaired Impaired Impaired Impaired Nonimpaired Nonimpaired NA Nonimpaired Nonimpaired Nonimpaired Nonimpaired NA Control subjects 2.0 (3.3) 0.07 (0.58) 2.6 (1.1) (n 138) a Alzheimer s disease 19.6 (13.4) 23.3 (17.3) (n 113) a Senile dementia of Lewy body type (n 61) a 110 (134) NA, not available. a Data taken for comparison from Perry et al (1990b, 1996) using the same criteria. Values are mean (SD).
5 134 BIOL PSYCHIATRY J. O Brien et al cant cognitive dysfunction in our patients during their depression. Consistent with this, we found no difference between impaired and nonimpaired groups for atheromatous degeneration score that reflected cerebral and systemic large and medium vessel pathology. Although many studies have examined neurotransmitter and receptor changes during depression, there has been only very limited focus on neuropathologic changes. This is partly because affective illness has been viewed as a state-dependent, reversible condition. This is, particularly in the elderly, now known to be flawed, as elderly depressed subjects have both enduring cognitive impairments (Abas et al 1990) and demonstrable neurobiological changes, which suggest structural abnormalities. For example, depressed subjects have increased cortical atrophy and ventricular enlargement when compared to control subjects (Elkis et al 1995; Jacoby and Levy 1980; Rabins et al 1991). In an MRI study, Rabins et al (1991) was unable to differentiate those with depression and Alzheimer s disease on the basis of either cortical atrophy or the presence of white matter change. Our findings show that the causes of cognitive impairment and structural brain changes in depression lie outside those of degenerative or microvascular pathology. Results are consistent with the notion that deficits in some areas, particularly in learning and memory, may be related to excess cortisol secretion as a result of hypothalmic pituitary adrenal axis activation during the illness (O Brien 1997). Several lines of evidence support this view. First, in animal models prolonged raised corticosteroid secretion is associated with deficits in learning and memory and hippocampal cell loss (Sapolsky and Plotsky 1990; Sapolsky et al 1986). Second, the hippocampus is a major site of glucocorticoid receptors, and at a cellular level excess glucocorticoids increase calcium dependent influx, which is known to be neurotoxic (Landfield and Eldridge 1994). Third, following exogenous steroid administration or raised endogenous levels as a result of stress, cognitive deficits can be demonstrated in healthy subjects (Kirschbaum et al 1996). Fourth, in Cushing s syndrome excess cortisol production is associated with cognitive impairments and hippocampal change (Starkman et al 1992). Finally, depression has been shown to be associated with mild hippocampal atrophy (Sheline et al 1999), which correlates with the total duration of depression. To determine whether hippocampal cell loss is a cause of cognitive decline associated with depression, further neuropathologic study of cell morphometry in the hippocampus would need to be performed. Cognitive impairments during depression have also been associated with abnormalities in other brain areas, particularly the medial prefrontal cortex (Dolan et al 1992). Changes in similar brain areas have also been described on MRI (Drevets et al 1997), and a preliminary neuropathologic report suggests glial loss in the absence of neuronal loss in one part of the prefrontal cortex, at least in younger patients with depression (Drevets et al 1998). Changes in these or related areas may also underlie some of the neuropsychological impairments that occur during depression. Salloway et al (1996) found white matter lesions to be associated with impairments in attentional function. Although such lesions may be an important correlate of impairment, we could find no evidence that this was accompanied by microvascular change, at least in the cortical areas that we examined (which did include frontal cortex). The tests of cognition used in this study, however, the MMSE and the MTS, are global measures of cognitive function not particularly sensitive to executive function, processing speed and other tasks subserved by frontal subcortical areas. Because these are the regions most affected in imaging studies (Coffey et al 1993; Greenwald et al 1998), it may be that there would be correlations between microvascular pathology in these regions and more specific frontal tests. Some other limitations of our study should be considered. Our cases were not prospectively assessed, and so information regarding their depressive illness and cognitive function came from case notes; however, case notes within the service were of a very high quality, with detailed typed summaries. All cases had detailed comment about cognitive performance, and the majority had received a standardized assessment of cognitive function. Numbers of depressed subjects were small and, although the cognitive impairment documented during the depressive illness was felt to be secondary to depression, we were not able to document reversibility on recovery from the depression and so cannot be certain that this impairment was not due to another cause. Although this may have been a possible confounding explanation if we had found an increase in microvascular or Alzheimer type pathology in the group with cognitive impairment, we do not feel this can explain our negative results. Although our subjects were impaired on clinical measures of cognition, scores were in the moderate range and it may be that by studying a group with more pronounced cognitive impairments during depression correlations with neurodegenerative pathology may exist. In summary, we found no evidence of neuropathologic differences between cognitively impaired and nonimpaired depressed subjects. This supports the view that cognitive dysfunction in depression is mediated by mechanisms that are different from those related to Alzheimer s disease or vascular dementia. Hypercortisolaemia is one possible explanation. There also needs to be further study of the possible neurochemical basis of cognitive impairments in depression, as previous reports have suggested
6 Neuropathology of Cognitive Impairment BIOL PSYCHIATRY 135 cholinergic loss may be important (Perry et al 1978). To investigate this further, in vivo study of subjects who have undergone detailed neuropsychological testing, assessment of endocrine function, and brain imaging should be combined with clinico-pathological study that includes detailed assessment of hippocampal cell morphometry, investigation of glucocorticoid receptor changes, and detailed neurochemical analysis. The authors thank the Medical Research Council and the Stanley Foundation for financial support. References Abas MA, Sahakian BJ, Levy R (1990): Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med 20: Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997): Vascular depression hypothesis. Arch Gen Psychiatry 54: American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association. Austin M-P, Mitchell P, Wilhelm K, Parker G, Hickie I, Brodaty H, et al (1999): Cognitive function in depression: A distinct pattern of frontal impairment? Psychol Med 29: Beats BC, Sahakian BJ, Levy R (1996): Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 26: Blessed G, Tomlinson BE, Roth M (1968): The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: Braak H, Braak E (1991): Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: Bulbena A, Berrios GE (1986): Pseudodementia: Facts and figures. Br J Psychiatry 148: Chimowitz MI, Estes ML, Furlan AJ, Awad IA (1992): Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 49: Coffey CE, Figiel GS, Djang WT, Weiner RD (1990): Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 147: Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, et al (1993): Quantitative cerebral anatomy in depression: A controlled magnetic resonance imaging study. Arch Gen Psychiatry 50:7 15. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RS (1992): Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 55: Drevets WC, Ongur D, Price JL (1998): Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders. Mol Psychiatry 3: Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997): Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: Elkis H, Friedman L, Wise A, Meltzer HY (1995): Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 52: Elliot R (1998): The neuropsychological profile in unipolar depression. Trends Cogn Sci 2: Esiri MM, Wilcock GK, Morris JH (1997): Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63: Figiel GS, Krishnan KR, Doraiswamy PM, Rao VP, Nemeroff CB, Boyko OB (1991): Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 12: Folstein MF, Folstein SE, McHugh PR (1975): Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Auerbach C, Patel M (1998): Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 29: Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM, Patel M (1996): MRI signal hyperintensities in geriatric depression. Am J Psychiatry 153: Hickie I, Scott E (1998): Late-onset depressive disorders: A preventable variant of cerebrovascular disease? Psychol Med 28: Hickie I, Scott E, Wilhelm K, Brodaty H (1997): Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression a longitudinal evaluation. Biol Psychiatry 42: Jacoby RJ, Levy R (1980): Computed tomography in the elderly. 3. Affective disorder. Br J Psychiatry 136: Jorm AF, Van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al (1991): Psychiatric history and related exposures as risk factors for Alzheimer s disease: A collaborative re-analysis of case-control studies. EURODEM. Int J Epidemiol 20: Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996): Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58: Kral VA, Emery OB (1989): Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry 34: Krishnan KR, McDonald WM (1995): Arteriosclerotic depression. Med Hypotheses 44: Landfield PW, Eldridge JC (1994): Evolving aspects of the glucocorticoid hypothesis of brain aging: hormonal modulation of neuronal calcium homeostasis. Neurobiol Aging 15: McAllister TW (1985): Recognition of pseudodementia. Am Fam Physician 32: O Brien J, Desmond P, Ames D, Schweitzer I, Harrigan S, Tress B (1996): A magnetic resonance imaging study of white matter lesions in depression and Alzheimer s disease. Br J Psychiatry 168:
7 136 BIOL PSYCHIATRY J. O Brien et al O Brien JT (1997): The glucocorticoid cascade hypothesis in man. Br J Psychiatry 170: Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978): Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: Perry R, Jaros E, Irving D, Scoones D, Brown A, McMeekin W, et al (1996): What is the neuropathological basis of dementia associated with Lewy bodies? In: RH Perry, IG McKeith, EK Perry editors. Dementia with Lewy Bodies, Vol 1. Cambridge, UK: Cambridge University Press, Perry RH (1993): Coronal Maps of Brodmann Areas in the Human Brain. London: Wolfe. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990a): Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: Perry RH, Irving D, Tomlinson BE (1990b): Lewy body prevalence in the aging brain: Relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J Neurol Sci 100: Rabins PV, Pearlson GD, Aylward E, Kumar AJ, Dowell K (1991): Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 148: Salloway S, Malloy P, Kohn R, Gillard E, Duffy J, Rogg J, et al (1996): MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 46: Sapolsky RM, Krey LC, McEwen BS (1986): The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev 7: Sapolsky RM, Plotsky PM (1990): Hypercortisolism and its possible neural bases. Biol Psychiatry 27: Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999): Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992): Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing s syndrome. Biol Psychiatry 32:
STRUCTURAL ABNORMALITY ON BRAIN MAGNETIC RESONANCE IMAGING IN LATE-ONSET MAJOR DEPRESSIVE DISORDER
Structural abnormalities on MRI in late-onset major depression STRUCTURAL ABNORMALITY ON BRAIN MAGNETIC RESONANCE IMAGING IN LATE-ONSET MAJOR DEPRESSIVE DISORDER Hsiu-Fen Lin, Yu-Ting Kuo, 1 I-Chan Chiang,
More informationNACC Vascular Consortium. NACC Vascular Consortium. NACC Vascular Consortium
NACC Vascular Consortium NACC Vascular Consortium Participating centers: Oregon Health and Science University ADC Rush University ADC Mount Sinai School of Medicine ADC Boston University ADC In consultation
More informationNIH Public Access Author Manuscript Am J Geriatr Psychiatry. Author manuscript; available in PMC 2012 January 1.
NIH Public Access Author Manuscript Published in final edited form as: Am J Geriatr Psychiatry. 2011 January ; 19(1): 4 12. doi:10.1097/jgp.0b013e3181d6c245. Change in hippocampal volume on magnetic resonance
More informationNeuropathology of Neurodegenerative Disorders Prof. Jillian Kril
Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration
More informationSynaptic changes in dementia: links to cognition and behaviour
Synaptic changes in dementia: links to cognition and behaviour Paul T Francis, PhD Professor of Neurochemistry Director, Brains for Dementia Research Agenda Discuss synaptic changes in various dementias
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationA prospective study of dementia with Lewy bodies
Age and Ageing 998; 27: 6-66 998, British Geriatrics Society A prospective study of dementia with Lewy bodies CLIVE G. BALLARD, JOHN O'BRIEN, KATH LOWERX GARETH A. AYRE, RICHARD HARRISON, ROBERT PERRY,
More informationLewy body disease (LBD) is the second most common
REGULAR ARTICLES Lewy Body Disease: Can We Diagnose It? Michelle Papka, Ph.D. Ana Rubio, M.D., Ph.D. Randolph B. Schiffer, M.D. Christopher Cox, Ph.D. The authors assessed the accuracy of published clinical
More informationV ascular dementia is recognised as one of the most common
PAPER Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss J J Kril, S Patel, A J Harding, G M Halliday... See end of article for authors affiliations...
More informationImaging of Alzheimer s Disease: State of the Art
July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression
More informationAlzheimer disease (AD) is a devastating neurodegenerative
ORIGINAL ARTICLE Rates of Depression in Individuals With Pathologic But Not Clinical Alzheimer Disease are Lower Than Those in Individuals Without the Disease: Findings From the Baltimore Longitudinal
More informationFDG-PET e parkinsonismi
Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism
More informationAnxiety, Depression, and Dementia/Alzheimer Disease: What are the Links?
The 2016 Annual Public Educational Forum Anxiety, Depression, and Dementia/Alzheimer Disease: What are the Links? Mary Ganguli MD MPH Professor of Psychiatry, Neurology, and Epidemiology, University of
More informationWHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
More informationPsychology, 3 Department of Anatomy, Histology and Embryology,
PROCEEDINGS OF THE BALKAN SCIENTIFIC CONFERENCE OF BIOLOGY IN PLOVDIV (BULGARIA) FROM 19 TH TILL 21 ST OF MAY 2005 (EDS B. GRUEV, M. NIKOLOVA AND A. DONEV), 2005 (P. 115 124) QUANTITATIVE CEREBRAL ANATOMY
More informationVisual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London
Visual Rating Scale Reference Material Lorna Harper Dementia Research Centre University College London Background The reference materials included in this document were compiled and used in relation to
More informationHallucinations and signs of parkinsonism help distinguish patients with dementia and cortical
161Journal of Neurology, Neurosurgery, and Psychiatry 1997;62:16-21 Alzheimer's Treatment and Research Center, Department of Neurology, Ramsey Clinic/Health- Partners, University of Minnesota, St Paul,
More informationNeuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies
Article Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies Clive G. Ballard, M.R.C.Psych., M.D. Robin Jacoby, F.R.C.Psych.,
More informationAnosognosia, or loss of insight into one s cognitive
REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and
More informationDiffusion Tensor Imaging in Psychiatry
2003 KHBM DTI in Psychiatry Diffusion Tensor Imaging in Psychiatry KHBM 2003. 11. 21. 서울대학교 의과대학 정신과학교실 권준수 Neuropsychiatric conditions DTI has been studied in Alzheimer s disease Schizophrenia Alcoholism
More informationOLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.
Psychiatric disorders of the elderly OLD AGE PSYCHIATRY Dementia Depression Delusional disorder/late onset schizophrenia Delirium Dementia definition LOCALISATION OF CEREBRAL FUNCTION Impairment of multiple
More informationORIGINAL CONTRIBUTION. Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease
ORIGINAL CONTRIBUTION Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease Vahram Haroutunian, PhD; Daniel P. Perl, MD; Dushyant P. Purohit,
More informationDisease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland
Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the
More informationCASE 49. What type of memory is available for conscious retrieval? Which part of the brain stores semantic (factual) memories?
CASE 49 A 43-year-old woman is brought to her primary care physician by her family because of concerns about her forgetfulness. The patient has a history of Down syndrome but no other medical problems.
More informationNeuroimaging for Diagnosis of Psychiatric Disorders
Psychiatric Disorder Neuroimaging for Diagnosis of Psychiatric Disorders JMAJ 45(12): 538 544, 2002 Yoshio HIRAYASU Associate Professor, Department of Neuropsychiatry Kyorin University School of Medicine
More informationGross morphological brain changes with chronic, heavy cannabis use
University of Wollongong Research Online Faculty of Social Sciences - Papers Faculty of Social Sciences 2015 Gross morphological brain changes with chronic, heavy cannabis use Valentina Lorenzetti University
More informationNeuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia
86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationClinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationORIGINAL CONTRIBUTION. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease
ORIGINAL CONTRIBUTION Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease Vahram Haroutunian, PhD; Dushyant P. Purohit, MD; Daniel P. Perl, MD; Deborah Marin, MD; Khalid
More informationBrain imaging for the diagnosis of people with suspected dementia
Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis
More informationCerebral amyloid angiopathy in dementia and old age
Journal of Neurology, Neurosurgery, and Psychiatry 1986;49:1221-1226 Cerebral amyloid angiopathy in dementia and old age MARGARET M ESIRI, G K WILCOCK* From the Departments of Neuropathology and Geriatric
More informationNew life Collage of nursing Karachi
New life Collage of nursing Karachi Presenter: Zafar ali shah Faculty: Raja khatri Subject: Pathophysiology Topic :Alzheimer s Disease Post RN BScN semester 2 nd Objective Define Alzheimer s Describe pathophysiology
More informationAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative
ORIGINAL RESEARCH E. Matsusue S. Sugihara S. Fujii T. Kinoshita T. Nakano E. Ohama T. Ogawa Cerebral Cortical and White Matter Lesions in Amyotrophic Lateral Sclerosis with Dementia: Correlation with MR
More informationYin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5
More informationPentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer s disease
J Neurol Neurosurg Psychiatry 2001;70:483 488 483 Center for Alzheimer Disease and Related Disorders, Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
More informationW hite matter lesions (WML) in elderly people result
1304 PAPER Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly S Artero, H Tiemeier, N D Prins, R Sabatier, M M B Breteler, K Ritchie... See end of article for authors
More informationAge, Neuropathology, and Dementia
The new england journal of medicine original article Age, Neuropathology, and Dementia George M. Savva, Ph.D., Stephen B. Wharton, F.R.C.Path., Paul G. Ince, M.D., Gillian Forster, B.Sc., Fiona E. Matthews,
More informationALLEN Human Brain Atlas
TECHNICAL WHITE PAPER: CASE QUALIFICATION AND DONOR PROFILES The case review process described here was employed for three components of the ALLEN Human Brain Atlas: (1) the Survey; (2) the Neurotransmitter
More informationORIGINAL CONTRIBUTION. Diagnostic Accuracy of Dementia With Lewy Bodies. to be the second
ORIGINAL CONTRIBUTION Diagnostic Accuracy of Dementia With Lewy Bodies Ursula Hohl, MD; Pietro Tiraboschi, MD; Lawrence A. Hansen, MD; Leon J. Thal, MD; Jody Corey-Bloom, MD, PhD Background: Diagnostic
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationSubject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68
Subject Index Adams, R.D. 4 Addenbrooke s Cognitive Examination 101 Alzheimer s disease clinical assessment histological imaging 104 neuroimaging 101 104 neuropsychological assessment 101 clinical presentation
More informationVascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center
Vascular Dementia Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center none Disclosures Objectives To review the definition of Vascular Cognitive Impairment (VCI);
More informationLate-onset major depression: clinical and treatment-response variability
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 661 667. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1334 Late-onset major depression:
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More informationCaring Sheet #11: Alzheimer s Disease:
CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses
More informationDementia and Healthy Ageing : is the pathology any different?
Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association
More informationPiano playing skills in a patient with frontotemporal dementia: A longitudinal case study
International Symposium on Performance Science ISBN 978-94-90306-01-4 The Author 2009, Published by the AEC All rights reserved Piano playing skills in a patient with frontotemporal dementia: A longitudinal
More informationALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey
ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact
More informationDementia and Alzheimer s disease
Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase
More informationCognitive Decline in Patients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type
Age and Ageing 1996.25:209-21 3 Cognitive Decline in atients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type C. BALLARD, A. ATEL, F. OYEBODE, G. WILCOCK Summary One hundred
More informationVascular risk factors in late onset mania
Psychological Medicine, 2002, 32, 359 362. 2002 Cambridge University Press DOI: 10.1017 S0033291701004718 Printed in the United Kingdom BRIEF COMMUNICATION Vascular risk factors in late onset mania FREDERICK
More informationA Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong
A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong Outline The pathogenesis of Late life cognitive impairment A framework
More informationDementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician
Dementia Aetiology, pathophysiology and the role of neuropsychological testing Dr Sheng Ling Low Geriatrician Topics to cover Why is dementia important What is dementia Differentiate between dementia,
More informationLeukoencephalopathy in Normal and PathologiC Aging: 1. CT of Brain Lucencies
561 Leukoencephalopathy in Normal and PathologiC Aging: 1. CT of Brain Lucencies Ajax E. George 1 Mony J. de Leon 2 Cynthia I. Gentes 2 Jeff Miller 1.2 Eric London 2 Gleb N. Budzilovich 3 Steven Ferris2
More informationNeuro degenerative PET image from FDG, amyloid to Tau
Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging
More informationIntroduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge
Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes
More informationORIGINAL ARTICLE. Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease
ORIGINAL ARTICLE Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease Pietro Tiraboschi, MD; Larry A. Hansen, MD; Michael Alford, BA; Annette Merdes, MD;
More informationSupplementary Online Content
Supplementary Online Content Curtis C, Gamez JE, Singh U, et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol. Published online January
More informationNeurotransmitter: dopamine. Physiology of additive drugs. Dopamine and reward. Neurotransmitter: dopamine
Physiology of additive drugs Cocaine, methamphetamine, marijuana, and opiates influence the neurotransmitter dopamine. Neurotransmitter: dopamine Dopamine - a neurotransmitter associated with several functions,
More informationA lzheimer s disease has many neuropsychiatric manifestations
1396 PAPER Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer s disease G A Marshall, D I Kaufer, O L Lopez, G R Rao, R L Hamilton, S T DeKosky... See end of article for
More informationNeuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens
Neuro-Imaging in dementia: Philip Scheltens Alzheimer Center VU University Medical Center Amsterdam The Netherlands 1 Outline of talk Current guidelines Imaging used to exclude disease Specific patterns
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationPathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits
More informationDementia. Assessing Brain Damage. Mental Status Examination
Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological
More informationComparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions
Postgrad Med J (1993) 69, 696-700 A) The Fellowship of Postgraduate Medicine, 199: Comparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationEXECUTIVE dysfunction, including
ORIGINAL ARTICLE Executive Dysfunction and Long-term Outcomes of Geriatric Depression George S. Alexopoulos, MD; Barnett S. Meyers, MD; Robert C. Young, MD; Balu Kalayam, MD; Tatsuyuki Kakuma, PhD; Michelle
More informationQuantitative analysis for a cube copying test
86 99 103 2010 Original Paper Quantitative analysis for a cube copying test Ichiro Shimoyama 1), Yumi Asano 2), Atsushi Murata 2) Naokatsu Saeki 3) and Ryohei Shimizu 4) Received September 29, 2009, Accepted
More informationDelirium & Dementia. Nicholas J. Silvestri, MD
Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts
More informationNACC Neuropathology (NP) Diagnosis Coding Guidebook
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationVascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES. VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology
Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology HANDLING the BRAIN at AUTOPSY: What to FIX vs. what to FREEZE? --no need to be
More informationAssessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin
Assessing Cognition Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin Agenda Topic: Cognitive Aging Assessing Cognition Diagnosing Cognitive Impairment Dementia Diagnoses Symptoms
More informationSouthwest Brain Bank
Southwest Brain Bank Texas Tech University Health Sciences Center Paul L. Foster School of Medicine Department of Psychiatry Peter Thompson, M.D., M.S. Director Angelica Forero, M.A. Senior Research Scientist
More informationDOWNLOAD PDF THE EFFECT OF AEROBIC EXERCISE ON INFORMATION PROCESSING IN OLDER ADULTS
Chapter 1 : Exercise - Wikipedia Aerobic exercise (two RCTs), strength exercise alone (one RCT) or combined with balance and exercise (one RCT) or a combination of aerobic, strength. balance and flexibility
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More informationCISC 3250 Systems Neuroscience
CISC 3250 Systems Neuroscience Levels of organization Central Nervous System 1m 10 11 neurons Neural systems and neuroanatomy Systems 10cm Networks 1mm Neurons 100μm 10 8 neurons Professor Daniel Leeds
More informationACENTRAL TENET OF ALZHEIMER
CLINICAL INVESTIGATION Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease Kenneth L. Davis, MD Richard C. Mohs, PhD Deborah Marin, MD Dushyant P. Purohit, MD Daniel P. Perl,
More informationPSYC& 100: Biological Psychology (Lilienfeld Chap 3) 1
PSYC& 100: Biological Psychology (Lilienfeld Chap 3) 1 1 What is a neuron? 2 Name and describe the functions of the three main parts of the neuron. 3 What do glial cells do? 4 Describe the three basic
More informationbiological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40
biological psychology, p. 40 The specialized branch of psychology that studies the relationship between behavior and bodily processes and system; also called biopsychology or psychobiology. neuroscience,
More informationParkinson e decadimento cognitivo. Stelvio Sestini
Parkinson e decadimento cognitivo Stelvio Sestini Patients with PD can develop a spectrum of cognitive symptoms Heterogeneity of cognitive deficits The cognitive symptoms can evolve to dementia (Mov Disorder
More informationT he concept of vascular cognitive covers a
28 PAPER Cognitive profile of subcortical ischaemic vascular disease H Jokinen, H Kalska, R Mäntylä, T Pohjasvaara, R Ylikoski, M Hietanen, O Salonen, M Kaste, T Erkinjuntti... J Neurol Neurosurg Psychiatry
More informationWhite matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer s disease, vascular dementia, and normal aging
66 Institute for the Health of the Elderly R Barber A Gholkar I McKeith RPerry J O Brien MRC Neurochemical Pathology Unit, Newcastle General Hospital, Newcastle upon Tyne, UK C Ballard P Ince Department
More informationParkinson' s disease: comparisons with Alzheimer' s
Journal of Neurology, Neurosurgery, and Psychiatry 1985;48:413-421 Cholinergic correlates of cognitive impairment in Parkinson' s disease: comparisons with lzheimer' s disease ELINE K PERRY,* MICHEL CURTIS,t
More informationChronic Traumatic Encephalopathy Provider and Parent Essentials
Chronic Traumatic Encephalopathy Provider and Parent Essentials Concussion Global Cast July 30, 2014 John Lockhart, MD Seattle Children s Hospital Chronic Traumatic Encephaly (CTE) Working Definition Chronic
More informationORIGINAL CONTRIBUTION. Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease
ORIGINAL CONTRIBUTION Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease Clive Ballard, MRCPsych, MD; John O Brien, MRCPsych, DM; Alistair Gray, BSc; Franchesca
More informationProbable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies
Case Report Taiwanese Journal of Psychiatry (Taipei) Vol. 25 No. 1 2011 45 Probable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies Sin-Yi Chen, M.D. 1, Yuan-Han
More informationCognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background
Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis Victoria A Levasseur 1,2, Samantha Lancia 1, Gautam Adusumilli 1, Zach Goodman 1, Stuart D. Cook 3, Diego Cadavid 4, Robert T.
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationCEREBRUM. Dr. Jamila EL Medany
CEREBRUM Dr. Jamila EL Medany Objectives At the end of the lecture, the student should be able to: List the parts of the cerebral hemisphere (cortex, medulla, basal nuclei, lateral ventricle). Describe
More informationPRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans
PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans Inclusion Criteria Clinical syndrome Patients must have clinical evidence
More informationTGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci
Department of Clinical and Molecular Biomedicine Section of Pharmacology and Biochemistry Department of Educational Sciences University of Catania TGF-ß1 pathway as a new pharmacological target for neuroprotection
More informationJohnson, V. E., and Stewart, W. (2015) Traumatic brain injury: Age at injury influences dementia risk after TBI. Nature Reviews Neurology, 11(3), pp. 128-130. (doi:10.1038/nrneurol.2014.241) There may
More informationThe Nervous System. Biological School. Neuroanatomy. How does a Neuron fire? Acetylcholine (ACH) TYPES OF NEUROTRANSMITTERS
Biological School The Nervous System It is all about the body!!!! It starts with an individual nerve cell called a NEURON. Synapse Neuroanatomy Neurotransmitters (chemicals held in terminal buttons that
More informationBaseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston
Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,
More informationDepression: An Important Risk Factor for Cognitive Decline
Depression: An Important Risk Factor for Cognitive Decline No conflicts of interest Sarah K. Tighe, M.D. Assistant Professor University of Iowa Carver College of Medicine Department of Psychiatry Institute
More informationName: Period: Chapter 2 Reading Guide The Biology of Mind
Name: Period: Chapter 2 Reading Guide The Biology of Mind The Nervous System (pp. 55-58) 1. What are nerves? 2. Complete the diagram below with definitions of each part of the nervous system. Nervous System
More information